EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes

Amy Stein, Meghan Pauley, Janet Snell-Bergeon

Endocrinology and Metabolism Clinics of North America · 2026-09 · 55 (3) · 437-453

DOI: 10.1016/j.ecl.2026.04.003 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrinology and Metabolism Clinics of North America, 2026-09. Verfasst von Amy Stein und 2 weiteren Autor:innen. Beteiligte Einrichtung: Barbara Davis Center for Diabetes, Department of Pediatrics, University of Colorado School of Medicine, 1775 Aurora Ct, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Glucagon-Like Peptide-1 Receptor Agonists, Hypoglycemic Agents. Die Arbeit nennt 80 Literaturangaben. Gefördert von: NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 1 diabetes (T1D) results in lifelong insulin therapy, but most people with T1D do not achieve glycemic targets using insulin alone. Adjunctive therapies such as once-weekly glucagon-like peptide-1 receptor agonists (GLP-1 RA) are approved for type 2 diabetes and also treat obesity, which is a growing concern in people with T1D. In this article, we review what is currently known about weekly GLP-1RA treatment in people with T1D, we will discuss the gaps in knowledge remaining, and we will outline the additional trials needed to close these knowledge gaps.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsHumansGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Adjunctive therapyCardiovascular diseaseGlycemic controlObesityType 1 diabetes

Substanzen

Glucagon-Like Peptide-1 Receptor AgonistsHypoglycemic AgentsGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Barbara Davis Center for Diabetes, Department of Pediatrics, University of Colorado School of Medicine, 1775 Aurora Ct, Aurora, CO 80045, USA.
  • Barbara Davis Center for Diabetes, Department of Pediatrics, University of Colorado School of Medicine, 1775 Aurora Ct, Aurora, CO 80045, USA. Electronic address: JANET.SNELL-BERGEON@CUANSCHUTZ.EDU.

Förderung

  • NIDDK NIH HHS

Zitieren

APA

Stein, A., Pauley, M., & Snell-Bergeon, J. (2026). Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes. Endocrinology and Metabolism Clinics of North America, 55(3), 437-453. https://doi.org/10.1016/j.ecl.2026.04.003

Vancouver

Stein A, Pauley M, Snell-Bergeon J. Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes. Endocrinology and Metabolism Clinics of North America. 2026;55(3):437-453. doi:10.1016/j.ecl.2026.04.003

BibTeX
@article{Stein2026,
  author = {Stein, Amy and Pauley, Meghan and Snell-Bergeon, Janet},
  title = {Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 1 Diabetes},
  journal = {Endocrinology and Metabolism Clinics of North America},
  year = {2026},
  volume = {55},
  number = {3},
  pages = {437--453},
  doi = {10.1016/j.ecl.2026.04.003}
}
Kostenlos starten →